Tenet Healthcare (THC) Other financing activities (2009 - 2026)

Tenet Healthcare has reported Other financing activities for 18 years, with the latest figure at $73.0 million in Q2 2026.

• Quarterly Other financing activities rose 586.67% year-over-year to $73.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $73.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $55.0 million, down 5.17% from the prior year.
• Other financing activities improved to $73.0 million in Q2 2026 per THC's latest filing, from -$77.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $73.0 million in Q2 2026 and troughed at -$102.0 million in Q1 2022.
• A 5-year average of $8.1 million and a median of $17.5 million in 2023 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2023 and 2026: Other financing activities soared 2233.33% in 2023, then slumped 1000.0% in 2026.
• Over 5 years, Other financing activities stood at $3.0 million in 2022, then jumped by 2233.33% to $70.0 million in 2023, then retreated by 12.86% to $61.0 million in 2024, then sank by 36.07% to $39.0 million in 2025, then surged by 87.18% to $73.0 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $73.0 million, -$77.0 million, and $39.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.